homepageHomepage
pr_newswire PR Newswire
Portal
Portal
Search
Search
Member List
Member List
Help
Help
Hello There, Guest! Login Register
Login
Username:
Password:
Lost Password?
 
ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.
PR Newswire

Pages (764): « Previous 1 … 440 441 442 443 444 … 764 Next »
Jump to page 
Date & Time Title
Mon, 24 Mar 2025 09:03:00 +0800 Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology
Mon, 24 Mar 2025 09:00:00 +0800 HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar
Mon, 24 Mar 2025 09:00:00 +0800 ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy
Mon, 24 Mar 2025 09:00:00 +0800 ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
Mon, 24 Mar 2025 09:00:00 +0800 FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority
Mon, 24 Mar 2025 08:30:00 +0800 Evolve: The Latest GPU Benchmark Suite
Mon, 24 Mar 2025 08:15:00 +0800 CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
Mon, 24 Mar 2025 08:15:00 +0800 Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections
Mon, 24 Mar 2025 08:00:00 +0800 Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX
Mon, 24 Mar 2025 08:00:00 +0800 Strider Named to Fast Company's 2025 List of Most Innovative Companies
Mon, 24 Mar 2025 08:00:00 +0800 Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX
Mon, 24 Mar 2025 08:00:00 +0800 AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
Mon, 24 Mar 2025 08:00:00 +0800 Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
Mon, 24 Mar 2025 07:56:00 +0800 Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
Mon, 24 Mar 2025 07:30:00 +0800 Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
Mon, 24 Mar 2025 07:00:00 +0800 CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS
Mon, 24 Mar 2025 06:00:00 +0800 Confidence among small businesses in Singapore rises
Mon, 24 Mar 2025 05:00:00 +0800 Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence
Mon, 24 Mar 2025 05:00:00 +0800 Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings
Mon, 24 Mar 2025 03:00:00 +0800 Canopus Networks & UNSW Sydney Secure $433K Grant from Australian Government to Commercialize AI-Powered Cloud Security
Pages (764): « Previous 1 … 440 441 442 443 444 … 764 Next »
Jump to page 

Valuebuddies.com

Contact Us

Forum Team

Lite (Archive) Mode

Mark all forums read

RSS Syndication

Calendar

Return to Top

MyResponsive Theme © MyBB Themes, Powered By MyBB
Current time: 06-08-2025, 10:31 PM